FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (ipat, GDC-0068) in combination with paclitaxel (pac) as neoadjuvant treatment for early stage triple negative breast cancer (TNBC) Meeting Abstract
| Authors: | Saura, C.; Isakoff, S. J.; Calvo, I.; Patt, D.; Andersen, J.; Gonzalez-Martin, A.; Fisher, J.; Ciruelos, E.; Gil-Gil, M.; De la Pena, L.; Choi, Y.; Jia, S.; Singel, S.; Patel, P. H.; Baselga, J.; Oliveira, M. |
| Abstract Title: | FAIRLANE: A phase II randomized, double-blind, study of the Akt inhibitor ipatasertib (ipat, GDC-0068) in combination with paclitaxel (pac) as neoadjuvant treatment for early stage triple negative breast cancer (TNBC) |
| Meeting Title: | 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 76 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2015 Dec 8-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-02-15 |
| Language: | English |
| ACCESSION: | WOS:000375622402025 |
| DOI: | 10.1158/1538-7445.sabcs15-ot1-03-09 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OT1-03-09 -- Source: Wos |
